Wolfe Research Lowers Cigna (CI) Price Target but Keeps Outperform Rating

The Cigna Group (NYSE:CI) is one of the 11 Dirt Cheap Stocks to Buy According to Analysts. On October 15, Wolfe Research lowered its price target on The Cigna Group (NYSE:CI) from $345 to $325 and kept an Outperform rating.

Wolfe Research pointed out that even after moderating its numbers slightly, it still sees The Cigna Group’s (NYSE:CI) stock as cheap at about 9 times its revised 2026 EPS forecast.

Wolfe Research Lowers Cigna (CI) Price Target but Keeps Outperform Rating

The research firm believes The Cigna Group (NYSE:CI) is in a strong position to benefit from margin recovery efforts in its Stop Loss business and it also expects the Evernorth division to continue delivering solid performance.

Wolfe Research also sees The Cigna Group (NYSE:CI) as relatively defensively positioned given the current uncertainty around government rules and regulations in the healthcare industry.

The Cigna Group (NYSE:CI) is an American multinational managed healthcare and insurance company that offers products and services marketed under Cigna Healthcare, Evernorth Health Services, and other subsidiaries.

While we acknowledge the potential of CI as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CI and that has a 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 11 Best American Semiconductor Stocks to Invest In and 12 Best Fintech Stocks to Buy According to Analysts.

Disclosure: None. This article is originally published at Insider Monkey.